Clarient Diagnostic Service Inc
NeoGenomics is a leader in precision oncology diagnostics, offering an extensive range of over 500 tests that include advanced tissue-based, liquid biopsy, and heme tests to support personalized patient care. The company is dedicated to transforming cancer diagnostics through innovative solutions that align with the latest evidence and guidelines in the evolving landscape of oncology.
With a robust data set encompassing over 2 million patient profiles, NeoGenomics serves both healthcare providers and biopharma partners, facilitating drug development and clinical trials. Their commitment to comprehensive cancer testing and diagnostic insights plays a crucial role in guiding treatment decisions and improving patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

